| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.1971.00490010038005 |
| P698 | PubMed publication ID | 5146408 |
| P2093 | author name string | S O'Reilly | |
| P M Weber | |||
| L Shipley | |||
| M Oswald | |||
| P433 | issue | 1 | |
| P921 | main subject | physiology | Q521 |
| copper | Q753 | ||
| P304 | page(s) | 28-32 | |
| P577 | publication date | 1971-07-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper | |
| P478 | volume | 25 |
| Q34563495 | Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload |
| Q72625755 | Biliary excretion of copper in Fischer rats treated with copper salt and in Long-Evans cinnamon (LEC) rats with an inherently abnormal copper metabolism |
| Q34346879 | Chorea and related disorders. |
| Q67442385 | Copper and ceruloplasmin contents in the blood serum of peripheral and pre-hepatic veins |
| Q34476761 | Defective biliary excretion of copper in Wilson's disease |
| Q48016979 | Lysosomal Defect of Hepatic Copper Excretion in Wilson's Disease (Hepatolenticular Degeneration) |
| Q66936375 | Superoxide dismutase activity (erythrocuprein) in Wilson's disease |
| Q41925058 | Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy |
| Q34477827 | Treatment of Wilson's disease with zinc: XV long-term follow-up studies |
| Q37406597 | Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. |
| Q74547016 | Wilson disease and canine copper toxicosis |
| Q44166995 | Wilson's Disease: Indications for Liver Transplants |
| Q36211297 | Wilson's disease: Current status |
Search more.